Mirum Pharmaceuticals Statistics
Total Valuation
MIRM has a market cap or net worth of $2.30 billion. The enterprise value is $2.36 billion.
Important Dates
The next estimated earnings date is Wednesday, February 26, 2025, after market close.
| Earnings Date | Feb 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MIRM has 48.00 million shares outstanding. The number of shares has increased by 22.57% in one year.
| Current Share Class | 48.00M |
| Shares Outstanding | 48.00M |
| Shares Change (YoY) | +22.57% |
| Shares Change (QoQ) | +1.16% |
| Owned by Insiders (%) | 1.74% |
| Owned by Institutions (%) | 93.95% |
| Float | 37.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.21 |
| Forward PS | 5.66 |
| PB Ratio | 9.71 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.34, with a Debt / Equity ratio of 1.37.
| Current Ratio | 3.34 |
| Quick Ratio | 3.05 |
| Debt / Equity | 1.37 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.71 |
Financial Efficiency
Return on equity (ROE) is -39.84% and return on invested capital (ROIC) is -10.65%.
| Return on Equity (ROE) | -39.84% |
| Return on Assets (ROA) | -9.10% |
| Return on Capital (ROIC) | -10.65% |
| Revenue Per Employee | $1.16M |
| Profits Per Employee | -$378,072 |
| Employee Count | 264 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 3.83 |
Taxes
In the past 12 months, MIRM has paid $1.83 million in taxes.
| Income Tax | 1.83M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +84.05% in the last 52 weeks. The beta is 0.98, so MIRM's price volatility has been similar to the market average.
| Beta (5Y) | 0.98 |
| 52-Week Price Change | +84.05% |
| 50-Day Moving Average | 43.38 |
| 200-Day Moving Average | 36.62 |
| Relative Strength Index (RSI) | 69.93 |
| Average Volume (20 Days) | 432,852 |
Short Selling Information
The latest short interest is 6.43 million, so 13.40% of the outstanding shares have been sold short.
| Short Interest | 6.43M |
| Short Previous Month | 6.84M |
| Short % of Shares Out | 13.40% |
| Short % of Float | 17.14% |
| Short Ratio (days to cover) | 16.94 |
Income Statement
In the last 12 months, MIRM had revenue of $307.03 million and -$99.81 million in losses. Loss per share was -$2.12.
| Revenue | 307.03M |
| Gross Profit | 223.15M |
| Operating Income | -95.97M |
| Pretax Income | -107.43M |
| Net Income | -99.81M |
| EBITDA | -72.90M |
| EBIT | -95.97M |
| Loss Per Share | -$2.12 |
Full Income StatementBalance Sheet
The company has $284.45 million in cash and $317.65 million in debt, giving a net cash position of -$33.21 million or -$0.69 per share.
| Cash & Cash Equivalents | 284.45M |
| Total Debt | 317.65M |
| Net Cash | -33.21M |
| Net Cash Per Share | -$0.69 |
| Equity (Book Value) | 232.02M |
| Book Value Per Share | 4.84 |
| Working Capital | 270.88M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$1.23 million and capital expenditures -$973,000, giving a free cash flow of -$2.20 million.
| Operating Cash Flow | -1.23M |
| Capital Expenditures | -973,000 |
| Free Cash Flow | -2.20M |
| FCF Per Share | -$0.05 |
Full Cash Flow StatementMargins
Gross margin is 72.68%, with operating and profit margins of -31.26% and -32.51%.
| Gross Margin | 72.68% |
| Operating Margin | -31.26% |
| Pretax Margin | -31.91% |
| Profit Margin | -32.51% |
| EBITDA Margin | -23.74% |
| EBIT Margin | -31.26% |
| FCF Margin | n/a |
Dividends & Yields
MIRM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.57% |
| Shareholder Yield | -22.57% |
| Earnings Yield | -4.29% |
| FCF Yield | -0.09% |
Dividend DetailsAnalyst Forecast
The average price target for MIRM is $57.00, which is 18.80% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $57.00 |
| Price Target Difference | 18.80% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 35.70% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MIRM has an Altman Z-Score of 1.17 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.17 |
| Piotroski F-Score | 2 |